Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.
This finding comes from a small focus group of mothers living with HIV in Canada, most of them born in low-income nations.
Among 64 pregnant women who tested positive for SARS-CoV-2, none of their newborns tested positive.
There are many adults today who acquired HIV early in life. Learn about challenges and strength of young female long-term HIV survivors.
On average, it took 37 days for mothers-to-be to clear symptoms of coronavirus infection.
The Well Project asked A Girl Like Me blogger Heather O’Connor about breastfeeding as a woman living with HIV in the United States.
A new UNAIDS report indicates that ambitious targets to prevent and treat HIV in babies and children are not being met.
A 2018 report had suggested that HIV-positive women’s use of the drug at conception increased the risk of the rare birth defects.
For pregnant women with HIV, dolutegravir-based regimens are apparently safest.
The study randomized women starting HIV treatment during their third trimester to dolutegravir- or efavirenz-based antiretroviral regimens.
Updated recommendation includes testing for pregnant women during each pregnancy.
Pregnant women with HIV often don’t receive treatment per guidelines, according to a study of more than 1,800 HIV-positive pregnant women.
Sexually transmitted infections reach all-time highs, notably among young people.
Interim guidance from HIVMA and AIDSinfo covers lab visits, opioid treatment programs, pregnant women and more.
This may not lower PrEP’s efficacy, but very strict adherence to the daily Truvada regimen is key for pregnant women.
Viral load and CD4 percentage at the time of treatment initiation help predict how soon infants will become undetectable.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.